Related Experiment Videos
Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory
1Abteilung Strukturforschung Max-Planck-Institut für Biochemie, Martinsried, Germany.
Background:
Staurosporine inhibits most protein kinases at low nanomolar concentrations. As most tyrosine kinases, along with many serine/threonine kinases, are either proto oncoproteins or are involved in oncogenic signaling, the development of protein kinase inhibitors is a primary goal of cancer research. Staurosporine and many of its derivatives have significant biological effects, and are being tested as anticancer drugs. To understand in atomic detail the mode of inhibition and the parameters of high-affinity binding of staurosporine to protein kinases, the molecule was cocrystallized with the catalytic subunit of cAMP-dependent protein kinase.
Results:
The crystal structure of the protein kinase catalytic subunit with staurosporine bound to the adenosine pocket shows considerable induced-fit rearrangement of the enzyme and a unique open conformation. The inhibitor mimics several aspects of adenosine binding, including both polar and nonpolar interactions with enzyme residues, and induces conformational changes of neighboring enzyme residues.
Conclusions:
The results explain the high inhibitory potency of staurosporine, and also illustrate the flexibility of the protein kinase active site. The structure, therefore, is not only useful for the design of improved anticancer therapeutics and signaling drugs, but also provides a deeper understanding of the conformational flexibility of the protein kinase.
Insights
Staurosporine potently inhibits protein kinases by mimicking adenosine binding, inducing significant enzyme conformational changes. This detailed understanding aids in designing novel anticancer therapeutics and signaling drugs.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Protein kinases are crucial in cell signaling and cancer.
- Staurosporine is a potent inhibitor of many protein kinases.
- Developing kinase inhibitors is a key cancer research goal.
Purpose of the Study:
- To elucidate the atomic-level mechanism of staurosporine inhibition.
- To understand the binding parameters of staurosporine to protein kinases.
- To investigate staurosporine's interaction with cAMP-dependent protein kinase.
Main Methods:
- Cocrystallization of staurosporine with the catalytic subunit of cAMP-dependent protein kinase.
- X-ray crystallography to determine the complex's 3D structure.
Main Results:
- The crystal structure revealed an induced-fit rearrangement and a unique open conformation of the enzyme.
- Staurosporine effectively mimics adenosine binding through polar and nonpolar interactions.
- The inhibitor induced conformational changes in adjacent enzyme residues.
Conclusions:
- The findings explain staurosporine's high inhibitory potency.
- The study highlights the conformational flexibility of the protein kinase active site.
- The structure provides insights for designing improved anticancer and signaling drugs.